(PharmaNewsWire.Com, March 03, 2017 ) Rising government and non-government financial support for development of vaccine is the major driver for the pediatric vaccine market. Increasing innovative technologies such as therapeutic and adjuvant vaccines are anticipated to fuel the pediatric vaccine market during the forecast period. Moreover, increasing expenditure of vaccines, little accessibility to remote areas and strict regulation for approval of vaccines are some of the factors hampering the global pediatric vaccine market.
Infectious diseases segment is expected to grow at a faster rate during the forecast period. North America dominates the global market for pediatric vaccines followed by Europe. Moreover, the Asia Pacific is likely to report the highest CAGR during the forecast period, driven by the high birth rate in China and India.
Some of the key players in the market include Johnson and Johnson, Abbott Laboratories, Baxter International, Eli Lilly and Company, Sanofi S.A, Novo Nordisk A/S, Bharat Biotech International Limited, Actelion Pharmaceuticals Ltd, Genentech, Inc., Shire Pharmaceuticals Group Plc, Merck & Co. Inc, Bristol-Myers Squibb Company, Amgen Inc., Novartis AG and Boehringer Ingelheim GmbH.
Diseases type Covered: - Cancer and allergy - Infectious disease - Pneumococcal disease - Influenza - Diphtheria - Rotavirus - Tetanus - Haemophilus Influenzae type b (Hib) - Meningococcal - Hepatitis A - Hepatitis B - Rubella - Mumps - Measles - Pertussis - Varicella (chickenpox) - Polio
Regions Covered: - North America - US - Canada - Mexico - Europe - Germany - France - Italy - UK - Spain - Rest of Europe - Asia Pacific - Japan - China - India - Australia - New Zealand - Rest of Asia Pacific - Rest of the World - Middle East - Brazil - Argentina - South Africa - Egypt
10 Company Profiling 10.1 Johnson and Johnson 10.2 Abbott Laboratories 10.3 Baxter International 10.4 Eli Lilly and Company 10.5 Sanofi S.A 10.6 Novo Nordisk A/S 10.7 Bharat Biotech International Limited 10.8 Actelion Pharmaceuticals Ltd 10.9 Genentech, Inc. 10.10 Shire Pharmaceuticals Group Plc 10.11 Merck & Co. Inc 10.12 Bristol-Myers Squibb Company 10.13 Amgen Inc. 10.14 Novartis AG. 10.15 Boehringer Ingelheim GmbH
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: